Stocks and Investing Stocks and Investing
Mon, December 13, 2021
[ 12:00 AM ] - WOPRAI
Brian Peterson Initiated (BRZE) at Buy and Held Target at $85 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
David Hynes Initiated (BRZE) at Strong Buy and Held Target at $85 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Arjun Bhatia Initiated (BRZE) at Buy on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Ryan Macwilliams Initiated (BRZE) at Buy and Held Target at $95 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Yun Kim Initiated (BRZE) at Strong Buy and Held Target at $90 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
John Freeman Maintained (BSM) at Strong Buy with Decreased Target to $16 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (BLND) at Buy with Decreased Target to $15 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (ZM) at Hold with Decreased Target to $200 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Samik Chatterjee Maintained (AAPL) at Buy with Increased Target to $210 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Gabriela Borges Initiated (BIGC) at Strong Buy and Held Target at $60 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Manav Patnaik Maintained (BFAM) at Buy with Decreased Target to $155 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (ASAN) at Hold with Decreased Target to $80 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Benjamin Theurer Maintained (ADM) at Buy with Increased Target to $82 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Nick Delfas Upgraded (WMG) to Hold on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (VEEV) at Strong Buy with Decreased Target to $349 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Keay Nakae Downgraded (XCUR) to Hold and Decreased Target to $60 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Maxim Sytchev Initiated (CIGI) at Buy and Held Target at $170 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Maxim Sytchev Initiated (CIGI) at Buy on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (SMAR) at Buy with Increased Target to $105 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Joe Ritchie Downgraded (TKR) to Hold and Decreased Target to $73 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Deepa Raghavan Maintained (TOL) at Buy with Increased Target to $82 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Will Nance Maintained (TOST) at Hold with Decreased Target to $44 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
William Katz Maintained (TROW) at Strong Sell with Decreased Target to $167 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
Larry Biegelsen Maintained (TFX) at Buy with Decreased Target to $355 on, Dec 13th, 2021
[ 12:00 AM ] - WOPRAI
James Faucette Upgraded (TASK) to Buy and Increased Target to $55 on, Dec 13th, 2021
Sun, December 12, 2021
[ 12:00 AM ] - WOPRAI
Sheila Kahyaoglu Maintained (TDG) at Strong Buy and Held Target at $760 on, Dec 12th, 2021
Fri, December 10, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Maintained (ADBE) at Strong Buy and Held Target at $760 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (ARMK) at Hold with Increased Target to $39 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Franco Granda Initiated (APP) at Strong Buy and Held Target at $125 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Justin Kim Initiated (BCRX) at Buy and Held Target at $16 on, Dec 10th, 2021

Justin Kim Initiated (BCRX) at Buy and Held Target at $16 on, Dec 10th, 2021


Published on 2024-10-27 18:57:08 - WOPRAI, Justin Kim
  Print publication without navigation


Justin Kim of Oppenheimer, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy and Held Target at $16 on, Dec 10th, 2021.

Justin has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Justin's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $14 on, Thursday, November 4th, 2021


This is the rating of the analyst that currently disagrees with Justin

  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $17 on, Thursday, November 4th, 2021
Contributing Sources